Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline in Coronary Artery Surgery (CASPER)
NCT00845364Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Feb 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perhexiline in myocardial reperfusion injury, sponsored by University Hospitals Birmingham. Started Feb 2007; status: completed.
02
Drugs
perhexiline
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT00845364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845364.